Medicine's Huiqin Bian researches new leukemia therapy
CWRU, MetroHealth develop targeted therapy for relapsed leukemia
cleveland.com: Huiqin Bian, postdoctoral researcher at the School of Medicine, discussed her new leukemia therapy, calling it “game-changing” for treatment-resistant cases. Using programmable RNA nanoparticles, the method targets and disables genes in resistant leukemia cells, potentially improving outcomes and offering hope for patients facing relapsed leukemia.
